Skip to Content

Altria's Q3 Shows Why Tobacco Sector Is Misunderstood

We are retaining our $54 fair value estimate and wide moat rating.

Securities In This Article
Altria Group Inc
(MO)

Altria MO reported another robust performance in the third quarter, as evidence is gathering that tobacco has been one of the more defensive categories during the pandemic. Consolidated net revenue grew by 4.9% year over year on the back of a modest 2% underlying cigarette volume decline. Adjusted operating income grew by almost 9% over the same period a year ago, implying EBIT margin expansion of 2.2 percentage points, and adjusted earnings per share was flat. Given the lack of visibility into the near-term performance of many businesses, we are surprised that the market seems to have overlooked this resilient performance, and we think Altria is both mispriced and misunderstood. We are retaining our $54 fair value estimate and wide moat rating.

We estimate underlying cigarette shipment volume was down by 2% in the third quarter, offset by 6% pricing. This is a significant improvement from the 4% to 5% decline of recent years, for three reasons, in our view. First, the temporary effect of smokers staying at home and having more time and discretionary income to spend on smoking is increasing the frequency of consumption. This tailwind may ease after the pandemic passes. Second, the stabilization of Altria's premium price segments after losing share to the discount segment in recent quarters. Third, the structural effect of nicotine consumers switching back to smoking from vaping, following the clampdown on flavored liquids by the Food and Drug Administration, or FDA. While it is difficult to quantify the impact of these factors, and management has again refrained from reinstating medium-term guidance, we believe our medium-term estimate of a 3.5% annual volume decline in a normalized environment remains realistic, and assumes the vaping category does not materially rebound.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Stocks

About the Author

Philip Gorham

Strategist
More from Author

Philip Gorham, CFA, FRM, is a strategist, consumer equity research, for Morningstar Asia Limited, a wholly owned subsidiary of Morningstar, Inc. He relocated to Morningstar's Hong Kong office from Tokyo in November 2020. Gorham leads the equity analysts who cover Greater China equities and are based in Hong Kong, Shenzhen, and Singapore. Gorham continues to cover the European consumer staples sector, spanning beverages, consumer packaged goods, and tobacco products.

Gorham had extensive experience covering the consumer sector in Europe and the United States before moving to Asia in 2017. His most recent role was the director of equity research for Ibbotson Associates Japan, a Morningstar subsidiary

Gorham holds a bachelor's degree in economics from the University of Sunderland and master's degrees in business administration and accounting from the University of North Carolina. He also holds the Chartered Financial Analyst® and Financial Risk Manager® designations.

Sponsor Center